When analyzing the studies with <30% positive GLUT-1 expression independently, we concluded that GLUT-1 still predicted negative prognoses in cancers (HR=1.97, 95% CI: 1.26–3.07, heterogeneity p=0.054) (Figure 4). This evidence concerns the gene SLC2A1 and cancer.